Skip to content

Association between brain atrophy and intestinal permeability in patients with multiple sclerosis

Association between brain atrophy and intestinal permeability in patients with multiple sclerosis - Brain atrophy and intestinal permeability in MS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043910
Enrollment
40
Registered
2021-06-01
Start date
2021-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis

Interventions

A standard solution of lactulose (5 g) and mannitol (2 g)in 500 mL of tap water was ingested before bed. Urine was collected the following morning in a container (with 5 mL of thymol solution).

Sponsors

Department of Neurology and Neurological Science, Tokyo Medical and Dental University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: MS and related disorders (neuromyelitis optica spectrum disorders (NMOSD) and clinically isolated sydrome) will be included. MS is diagnosed by McDonald's criteria 2017 and NMOSD is diagnosed by Wingerchuk's criteria 2015.

Exclusion criteria

Exclusion criteria: Persons who have 1. pace makers or magnetic metals 2. claustrophobia 3. unstable general condition and vital signs 4. difficulty in informed consent 5. cancers or inflammatory bowel disease 6. diabetes mellitus , pregnant women and persons who is not suitable for the participants according to the doctor's decision.

Design outcomes

Primary

MeasureTime frame
Correlation between the rate of brain atrophy over 48 months and intestinal permeability measured at baseline.

Secondary

MeasureTime frame
Association between intestinal permeability at baseline and disease subtypes, disability, cognition, brain volume and disease modifying therapy

Countries

Japan

Contacts

Public ContactHiroaki Yokote

Nitobe Memorial Nakano General Hospital Department of Neurology

yktenuro@gmail.com0333821231

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026